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Leptospirosis is an endemic zoonosis of continental parts of Croatia with a sea-
sonal distribution pattern. On some occasions, in the infection's severe form
(Weil's disease), acute respiratory distress syndrome with pulmonary hemor-
rhage can occur. Here we present a case of Weil's disease with multiorgan fail-
ure, including hemorrhagic pneumonitis. The patient was succesfully treated by
veno-venous extracorporeal membrane oxygenation, with standard anticoagu-
lation, without enhancing the risk of bleeding, despite hemorrhagic pneumonitis
in leptospirosis.
Prikaz bolesnika
Leptospiroza je endemska zoonoza kontinentalne Hrvatske sa sezonskom dis-
tribucijom. Te{ki oblik bolesti, poznat kao Weilova bolest, mo`e se komplicirati
akutnim respiratornim distres sindromom i hemoragijskim pneumonitisom.
Prikazujemo bolesnicu s Weilovom bolesti i multiorganskim zatajenjem koje je
uklju~ivalo te{ki hemoragijski pneumonitis. Usprkos hemoragi~nom pneu-
monitisu, bolesnica je uspje{no lije~ena uz pomo} venovenske izvantjelesne
membranske oksigenacije koriste}i standardne antikoagulacijske mjere.
Introduction
In continental parts of Croatia leptospirosis is endemic
and shows a seasonal distribution pattern. Although pul-
monary involvement is not uncommon (in 20 to 70 % of
cases in different series), on some occasions in the infec-
tion's severe form (Weil's disease), acute respiratory dis-
tress syndrome (ARDS) with pulmonary hemorrhage can
occur – the frequency of such involvement has been on the
rise and is becoming the main cause of death from the dis-
ease. Mortality rates for severe lung involvement may be
as high as 50 %.
Here we present a case of Weil's disease with multior-
gan failure, including hemorrhagic pneumonitis, succes-
fully treated by veno-venous extracorporeal membrane
oxygenation (VV-ECMO).
Case report
A 72-year-old female patient without significant co-
morbidities presented in March 2016 with a five day histo-
ry of fever, sore throat, malaise, dyspnoea, mild diarrhea
and nausea. She came from a rural part of northern Croatia
and reported daily contact with bulls. On admission she
was icteric, tachydispnoic, febrile, hypoxemic (SpO2
77 %), GCS 15. Initial laboratory tests revealed leukocy-
tosis (14.6 × 10
9
/L), anemia (hgb 103 g/L), thrombocy-
topenia (40 × 109/L), elevated CRP (293.9 mg/L), procal-
citonin (44.6 μg/L), CK (548 U/L), kidney injury (BUN
17.7 mmol/L, creatinine 357 μmol/L) and conjugated hy-
perbilirubinemia (75 μmol/L). The chest radiograph showed
bilateral confluent parenchymal infiltrates (Figure 1). She
was admitted to the intensive care unit where empirical
antimicrobial therapy consisted of ceftriaxone, flucloxa-
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Discussion
Leptospirosis can manifest as a severe illness with high
morbidity leading to multiple organ dysfunction syn-
drome. It can present with a wide range of symptoms,
mimicking flu, hepatitis, dengue, hanta virus cardiopul-
monary syndrome, meningitis, among others, and has a
specific treatment; thus, clinical suspicion must remain
high and serological and molecular diagnosis should be
performed. Given the fact that leptospirosis is endemic
throughout the world, a clinican should be familiar in rec-
ognizing and treating the infection's severe form which
can also be accompanied by ARDS and pulmonary hem-
morhage. It should be remembered that not all cases of pul-
monary hemorrhage have a vascultic cause – infectious
diseases should be considered in the differential diagnosis
because early, adequate, targeted therapy in combination
with supportive treatment and, possibly, corticotherapy
will improve survival. The most frequent infections caus-
ing pulmonary hemorrhage (diffuse alveolar hemorrhage)
in immunocompetent patients are influenza, dengue, lep-
cillin and oseltamivir. Also, she was started on i.v. methyl-
prednisolone. The next morning the patient's condition
worsened with a progression of respiratory failure
prompting mechanical ventilation (MV). Due to the re-
fractory hypoxemic respiratory failure (pH 7.1, pCO2 40
mmHg, pO2 47 mmHg, pO2/FiO2 47) necessitating ag-
gressive MV which could not accomplish adequate oxy-
genation (PEEP 12, FiO2 100 %, plateau pressure >30 cm
H2O, oxygenation index 46.8), VV-ECMO was started, as
well as continuous renal replacement (CVVHDF). The
following day PCR of both serum and urine came positive
for Leptospira spp and the antimicrobial treatment was
de-escalated to ceftriaxone. Subsequently, leptospirosis
was also confirmed in paired sera by microscopic aggluti-
nation test. The total duration of VV-ECMO, MV, CVV-
HDF, ceftriaxone and methylprednisolone treatment was
6, 10, 15, 10 and 10 days, respectively. During the remain-
der of the hospitalization the patient's respiratory, renal
and other functions recovered and she was discharged af-
ter 6 weeks in good general condition (GOS 5, Karnofsky
score 80 %).
Figure 1. Bilateral confluent parenchymal patchy infiltrates – acute respiratory distress syndrome (ARDS)
Slika 1. Bilateralni konfluiraju}i infiltrati parenhima – akutni respiratorni distres sindrom (ARDS)
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tospirosis, malaria, and S. aureus pneumonia. In severe
presentations, supportive therapies are essential for sur-
vival, considering that multiorgan failure is typically com-
pletely reversible. As a last resort for treating severe
ARDS and pulmonary hemorrhage of any etiology, clini-
cians may need to use VV-ECMO if mechanical ventila-
tion does not suffice. VV-ECMO is a method of pul-
monary support that allows the lung to be relieved of its
gaseous exchange function minimizing the degree of lung
injury caused by MV with high FiO2, high tidal volumes
and increased airway pressures needed in severe respira-
tory failure and ARDS, ensuring protective ventilation
without further compromising oxygen delivery or acid
base balance. The benefits of ECMO use in hemorrhagic
pneumonitis and ARDS in leptospirosis are still under
evaluation. The importance of careful case selection has
become clear. Our patient had no significant comorbidi-
ties and was started on VV-ECMO relatively early (on the
sixth day of her illness, i.e. the following day after admis-
sion). VV-ECMO support was discontinued after six days,
and the patient eventually had full recovery.
This case report shows the importance of the fact that
VV-ECMO should be considered early as an option in
adult patients with severe respiratory failure especially if
the underlying cause is infective and therefore ultimately
curable. Finally, this case report shows that VV-ECMO
can be safely used with standard anticoagulation, without
enhancing the risk of bleeding, despite hemorrhagic pneu-
monitis in leptospirosis. 
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